Spyre Therapeutics, Inc. Common Stock

SYRENASDAQ • USD
94.18 USD
↘ 5.19 (5.22%)🟢LIVE (AS OF 11:27 AM EST)
🟢Market: OPEN

Shares of Spyre Therapeutics, Inc. Common Stock (SYRE) are trading at $94.18. There is a divergence between signals — technical indicators rate "Strong Buy" but underlying fundamentals lean "Sell". Notable factors include a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bullish Golden Cross on the moving averages. Valuation-wise, the stock is priced at a premium — multiples like P/E and EV/EBITDA sit above sector averages.

Technical & fundamental data as of Nov 16, 2026.

Open?$98.70
High?$100.97
Low?$85.71
Prev. Close?$99.37
Volume?263.2K
Avg. Volume?1.3M
VWAP?$96.37
Rel. Volume?0.21x
Bid / Ask
Bid?$94.49 × 100
Ask?$95.05 × 100
Spread?$0.56
Midpoint?$94.77
Valuation & Ratios
Market Cap?9.4B
Shares Out?95.0M
Float?80.1M
Float %?91.1%
P/E Ratio?N/A
P/B Ratio?8.97
EPS?-$2.36
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Spyre Therapeutics Inc is a clinical-stage biotechnology company pioneering long-acting antibodies and antibody combinations to redefine the standard of care for inflammatory bowel disease (IBD) and rheumatic diseases. Spyre's pipeline includes extended half-life antibodies targeting α4β7, TL1A, and IL-23 in development as monotherapies and pair-wise combinations. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.
Employees
130
Market Cap
9.9B
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2016-04-07
Address
221 CRESCENT STREET
WALTHAM, MA 02453
Phone: (617) 651-5940
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+3/3)
Medium-Term (Wave)?▲ Bullish(+1/3)
Short-Term (Ripple)?▼ Bearish(-2/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
100
Momentum?
23
Short Sent.?
33
Piotroski F-Score?0/9Weak
Altman Z-Score?115.99Safe
Confidence?52%Low
Full Fundamental Analysis →
Short InterestVery High
Short % of Float?14.50%High
Short Interest?11.6M
Days to Cover?12.7
Free Float80.1M
Avg Daily Volume915.4K
Settlement Date2026-10-30
Financial Health
Current Ratio?27.40Strong
Quick Ratio?27.40Strong
Cash Ratio?2.06Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
67/100
P/E?
N/A▾
P/B?
Peers
100
S&P
21
8.97HIGH▾
P/S?
N/A▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-29.2CHEAP▾
EV/Sales?
N/A▾
Returns & Efficiency
ROE?
S&P
7
-21.3%WEAK▾
ROA?
S&P
3
-20.4%WEAK▾
Cash Flow & Enterprise
FCF?$-249322000
Enterprise Value?$9.4B
Fundamentals ratios updated end of day